Patents by Inventor Michel Maillard

Michel Maillard has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7191335
    Abstract: A method of encryption of data in a digital television system communicated between a first decoder and a portable security module, wherein a precalculated key pair is stored in a memory of the first decoder, wherein the key pair includes a session key and an encrypted version of the session key prepared using a transport key, the encrypted version of the session key being subsequently communicated to the portable security module which decrypts the encrypted version using an equivalent transport key stored in its memory such that data communicated from at least the portable security module to the first decoder may thereafter be encrypted and decrypted by the session key.
    Type: Grant
    Filed: February 4, 2000
    Date of Patent: March 13, 2007
    Assignee: Canal + Technologies
    Inventor: Michel Maillard
  • Patent number: 7176242
    Abstract: Disclosed are compounds of the formula wherein the variables RN, RC, R1, R25, R2, and R3 are as defined herein. These compounds have activity as inhibitors of beta-secretase and are therefore useful in treating a variety of discorders such as Alzheimer's Disease.
    Type: Grant
    Filed: November 8, 2002
    Date of Patent: February 13, 2007
    Assignees: Elan Pharmaceuticals, Inc., Pharmacia & Upjohn Company
    Inventors: Varghese John, Michel Maillard, Barbara Jagodzinska, James Beck, Andrea Gailunas, John Freskos, John Mickelson, Lakshman Samala, Jennifer Sealy, Ruth TenBrink, Lawrence Fang, Roy Hom
  • Publication number: 20060154926
    Abstract: Disclosed are methods for treating Alzheimer's disease, and other diseases, and/or inhibiting beta-secretase enzyme, and/or inhibiting deposition of A beta peptide in a mammal, by use of compounds of formula (1) wherein the variables R1-R8 and X are defined herein.
    Type: Application
    Filed: June 11, 2003
    Publication date: July 13, 2006
    Inventors: Varghese John, Michel Maillard
  • Publication number: 20060135581
    Abstract: The invention relates to novel compounds and methods of treating diseases, disorders, and conditions associated with amyloidosis. Amyloidosis refers to a collection of diseases, disorders, and conditions associated with abnormal deposition of A-beta protein.
    Type: Application
    Filed: November 17, 2005
    Publication date: June 22, 2006
    Inventors: Varghese John, Michel Maillard, Barbara Jagodzinska, Jose Aquino, Gary Probst, Jay Tung
  • Publication number: 20060106256
    Abstract: This invention relates to prodrugs of a class of amine compounds which are useful in the treatment of Alzheimer's disease and similar diseases.
    Type: Application
    Filed: February 27, 2003
    Publication date: May 18, 2006
    Inventors: Varghese John, Barbara Jagodzinska, Michel Maillard, James Beck, Ruth TenBrink, Daniel Getman
  • Patent number: 7043020
    Abstract: A smartcard for use with a receiver of encrypted broadcast signals comprises a microprocessor for enabling or controlling decryption of said signals. A memory is coupled to the microprocessor. The microprocessor is adapted to enable or control the individual decryption of a plurality of such signals from respective broadcast suppliers of such signals by means of respective dynamically created zones in the memory, the dynamically created zones each being arranged to store decryption data associated with a respective one of said broadcast suppliers.
    Type: Grant
    Filed: January 25, 2002
    Date of Patent: May 9, 2006
    Assignee: Canal & Technologies
    Inventors: Michel Maillard, Christian Bernardeau
  • Publication number: 20060089355
    Abstract: Disclosed are methods for treating Alzheimer's disease, and other diseases, and/or inhibiting beta-secretase enzyme, and/or inhibiting de-position of A beta peptide in a mammal, by use of compounds of formula (I) wherein the variables R1, R2, R3, R4, R5, X1, and X2 are defined herein.
    Type: Application
    Filed: June 11, 2003
    Publication date: April 27, 2006
    Inventors: Michel Maillard, Varghese John
  • Patent number: 6987854
    Abstract: A method of transmitting and recording digital data scrambled using a control word. The scrambled data is transmitted together with the control word, and the method includes encrypting the control word with a first key. The encrypted control word is transmitted and received, and then decrypted with a decoder that includes an equivalent of the first key. The control word is re-encrypted with a second key stored in a portable support device that is received by the decoder, and the portable support device may be used with any suitable decoder. The re-encrypted control word and the scrambled digital data are recorded on a digital recording medium. An apparatus for transmitting and recording digital data scrambled using a control word. The scrambled data is transmitted together with the control word, and the apparatus includes a transmitter that encrypts the control word with a first key and transmits the encrypted control word. A decoder receives the encrypted control word and decrypts the control word.
    Type: Grant
    Filed: August 13, 2001
    Date of Patent: January 17, 2006
    Assignee: Thomson Licensing S.A.
    Inventor: Michel Maillard
  • Publication number: 20050261273
    Abstract: The invention relates to acetyl 2-hydroxy-1,3-diaminospirocyclohexanes and derivatives thereof that are useful in treating at least one disease, disorder, and condition associated with amyloidosis. Amyloidosis refers to a collection of diseases, disorders, and condition associated with abnormal deposition of A-beta protein.
    Type: Application
    Filed: March 9, 2005
    Publication date: November 24, 2005
    Inventors: Varghese John, Michel Maillard, John Tucker, Jose Aquino, Roy Hom, Jay Tung, Darren Dressen, Neerav Shah, R. Neitz
  • Publication number: 20050239832
    Abstract: The invention relates to novel compounds and methods of treating diseases, disorders, and conditions associated with amyloidosis. Amyloidosis refers to a collection of diseases, disorders, and conditions associated with abnormal deposition of A-beta protein.
    Type: Application
    Filed: March 9, 2005
    Publication date: October 27, 2005
    Inventors: Varghese John, Michel Maillard, Lawrence Fang, John Tucker, Louis Brogley, Jose Aquino, Simeon Bowers, Gary Probst, Jay Tung
  • Publication number: 20050239836
    Abstract: The invention relates to novel compounds and also to methods of treating at least one disease, disorder, or condition associated with amyloidosis using such compounds. Amyloidosis refers to a collection of diseases, disorders, and conditions associated with abnormal deposition of A-beta protein.
    Type: Application
    Filed: March 9, 2005
    Publication date: October 27, 2005
    Inventors: Varghese John, Michel Maillard, John Tucker, Jose Aquino, Barbara Jagodzinska, Louis Brogley, Jay Tung, Simeon Bowers, Darren Dressen, Gary Probst, Neerav Shah
  • Publication number: 20050239790
    Abstract: The invention relates to novel compounds and also to methods of treating at least one disease, disorder, or condition associated with amyloidosis using such compounds. Amyloidosis refers to a collection of diseases, disorders, and conditions associated with abnormal deposition of A-beta protein.
    Type: Application
    Filed: March 9, 2005
    Publication date: October 27, 2005
    Inventors: Varghese John, Michel Maillard, John Tucker, Barbara Jagodzinska, Louis Brogley, Jay Tung, Neerav Shah, R. Neitz
  • Publication number: 20050203096
    Abstract: The present invention is disubstituted amines of formula (I) and disubstituted amines of formula (II) useful in treating Alzheimer's disease and other similar diseases.
    Type: Application
    Filed: January 25, 2005
    Publication date: September 15, 2005
    Inventors: James Beck, Andrea Gailunas, Roy Hom, Barbara Jagodzinska, Varghese John, Michel Maillard
  • Publication number: 20050027014
    Abstract: The invention provides compounds of formula (I): useful in treating Alzheimer's disease and other similar diseases. These compounds include inhibitors of the beta-secretase enzyme that are useful in the treatment of Alzheimer's disease and other diseases characterized by deposition of A beta peptide in a mammal. The compounds of the invention are useful in pharmaceutical compositions and methods of treatment to reduce A beta peptide formation.
    Type: Application
    Filed: June 11, 2002
    Publication date: February 3, 2005
    Inventors: Michel Maillard, John Tucker
  • Patent number: 6846813
    Abstract: The present invention is disubstituted amines of formula (I) and disubstituted amines of formula (II) useful in treating Alzheimer's disease and other similar diseases.
    Type: Grant
    Filed: June 29, 2001
    Date of Patent: January 25, 2005
    Assignees: Pharmacia & Upjohn Company, Elan Pharmaceuticals, Inc.
    Inventors: James P. Beck, Andrea Gailunas, Roy Hom, Barbara Jagodzinska, Varghese John, Michel Maillard
  • Publication number: 20040180939
    Abstract: Disclosed are compounds of the formula: 1
    Type: Application
    Filed: September 10, 2003
    Publication date: September 16, 2004
    Inventors: Varghese John, Michel Maillard, James P. Beck, Eric T. Baldwin, Robert Hughes, Shon R. Pulley, Ruth TenBrink
  • Publication number: 20040171881
    Abstract: Disclosed are compounds of the formula 1
    Type: Application
    Filed: November 8, 2002
    Publication date: September 2, 2004
    Inventors: Varghese John, Michel Maillard, Barbara Jagodzinska, James Beck, Andrea Gailunas, John Freskos, John Mickelson, Lakshman Samala, Jennifer Sealy, Ruth TenBrink, Lawrence Fang, Roy Hom
  • Publication number: 20040114764
    Abstract: The present invention relates to a method for transmitting information between a transmitter station (100e) and a plurality of receiving stations (100r) wherein encrypted information is transmitted from the transmitter station to the receiver station with a first key and at least a control message bearing a second key. According to the invention, the first key used for decryption is restored in each receiving station from the second key and from at least one datum selected from a set of data available in the receiving stations, according to a selection command periodically transmitted between the transmitting station and the receiving station.
    Type: Application
    Filed: January 28, 2004
    Publication date: June 17, 2004
    Inventors: Jean-Luc Dauvois, Michel Maillard
  • Patent number: 6714650
    Abstract: A system for transmitting and recording digital data is included. Further, a system for transmitting transmit scrambled audio data that is to be recorded on a mini disc reader is included. A system for transmission and recording of digital data includes transmission means adapted to prepare and transmit scrambled digital data together with at least one encrypted control word and a digital recording device adapted to receive and record the scrambled digital data and encrypted control word on a digital support. The digital recording device further includes an access control means adapted to decrypt the control word and thereafter descramble the digital data during playback.
    Type: Grant
    Filed: August 11, 2000
    Date of Patent: March 30, 2004
    Assignee: Canal + Societe Anonyme
    Inventors: Michel Maillard, Christian Benardeau
  • Publication number: 20040044072
    Abstract: Disclosed are compounds of the formula 1
    Type: Application
    Filed: December 6, 2002
    Publication date: March 4, 2004
    Inventors: Ruth TenBrink, Michel Maillard, Martha Warpehoski